N
Nigel Spry
Researcher at Edith Cowan University
Publications - 205
Citations - 9846
Nigel Spry is an academic researcher from Edith Cowan University. The author has contributed to research in topics: Prostate cancer & Androgen deprivation therapy. The author has an hindex of 49, co-authored 195 publications receiving 8542 citations. Previous affiliations of Nigel Spry include Sir Charles Gairdner Hospital & Curtin University.
Papers
More filters
Journal ArticleDOI
Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial
TL;DR: A relatively brief exposure to exercise significantly improved muscle mass, strength, physical function, and balance in hypogonadal men compared with normal care and could be recommended for patients undergoing AST as an effective countermeasure to these common treatment-related adverse effects.
Journal ArticleDOI
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
TL;DR: The survival benefits seen in patients treated with adjuvant chemotherapy suggest that data from previous trials of adjUvant chemotherapy should be reassessed and the predictive value of MSI status confirmed.
Journal ArticleDOI
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
James W. Denham,Allison Steigler,David Lamb,David Joseph,Sandra Turner,John W. Matthews,Chris Atkinson,John North,David R. H. Christie,Nigel Spry,Keen Hun Tai,Chris Wynne,Catherine D'Este +12 more
TL;DR: 6 months of neoadjuvant androgen deprivation combined radiotherapy is an effective treatment option for locally advanced prostate cancer, particularly in men without nodal metastases or pre-existing metabolic comorbidities.
Journal ArticleDOI
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.
James W. Denham,Allison Steigler,David Lamb,David Joseph,Hedy Mameghan,Sandra Turner,John W. Matthews,Ian Franklin,Chris Atkinson,John B. North,Michael Poulsen,David R. H. Christie,Nigel Spry,Keen Hun Tai,Chris Wynne,Gillian M. Duchesne,Olga Kovacev,Catherine D'Este +17 more
TL;DR: 6 months' androgen deprivation given before and during radiotherapy improves the outlook of patients with locally advanced prostate cancer and is needed to estimate precisely the size of survival benefits.
Journal ArticleDOI
Resistance training and reduction of treatment side effects in prostate cancer patients.
Daniel A. Galvão,Kazunori Nosaka,Dennis R. Taaffe,Nigel Spry,Nigel Spry,Linda J. Kristjanson,Michael R. McGuigan,Katsuhiko Suzuki,Kanemitsu Yamaya,Robert U. Newton +9 more
TL;DR: Progressive resistance exercise has beneficial effects on muscle strength, functional performance and balance in older men receiving androgen deprivation for prostate cancer and should be considered to preserve body composition and reduce treatment side effects.